CompaniesByCap
TCRT
Alaunos Therapeutics Inc. (TCRT)
NASDAQ · Healthcare

Alaunos Therapeutics Inc. Income Statement 2011–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2018Dec 2017Dec 2016Dec 2012Dec 2011
Revenues
Revenue5,00010,0005,0002.9M398,0000146,0006.4M6.9M800,000667,000
Gross Profit
Profitability
Operating Income-4.2M-4.8M-34.3M-35.1M-77.5M-80.4M-53.9M-53.5M-165.3M-102.2M-71.4M
EBITDA-165.0M-101.5M-71.1M
Net Income-4.2M-4.7M-4.7M-37.7M-78.8M-80.0M-53.1M-54.3M-165.3M-96.1M-63.8M
Per Share Data
EPS (diluted)$-2.20$-2.92$-21.97$-2.61$-0.37$-0.38$0.96$-0.53$-1.32
Shares Outstanding (dil.)2M2M2M14M214M210M144M137M130M83M69M

Alaunos Therapeutics Inc. Income Statement — FAQ

Alaunos Therapeutics Inc. (TCRT) income statement over the last 11 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see TCRT's income statement history?

The chart and table above show Alaunos Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.